Click here to listen to today’s Diabetes Health in the News Podcast!
According to a new study published in Diabetes Care, gliptin treatment for diabetes is connected to an increased risk of pancreatitis. This study was completed at Jerusalem’s Hadassah-Hebrew University Hospital. It combined data on acute pancreatitis incidence from three large trials in order to examine the efficiency and cardiovascular safety of add-on glipitin treatment.
Researchers in the study found that patients treated with glipitin had a significantly increased acute pancreatitis incidence. There was a small difference in terms of absolute risk. Researchers believe that this information should be considered when prescribing gliptin treatments in the future.
These findings were published in Diabetes Care on September 22, 2016.